Equities

Vectura Group PLC

Vectura Group PLC

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (GBX)83.80
  • Today's Change-0.80 / -0.95%
  • Shares traded482.83k
  • 1 Year change14.67%
  • Beta0.7861
Data delayed at least 20 minutes, as of Dec 12 2019 16:35 GMT.
More ▼

Key statistics

On Thursday, Vectura Group PLC (VEC:LSE) closed at 83.80, -9.89% below its 52-week high of 93.00, set on Oct 18, 2019.
52-week range
Today
67.24Dec 27 201893.00Oct 18 2019
Markit short selling activity
Low
Med
High
Open84.30
High85.20
Low83.50
Bid--
Offer95.00
Previous close84.60
Average volume714.81k
Shares outstanding612.57m
Free float578.65m
P/E (TTM)--
Market cap518.23m GBP
EPS (TTM)-0.1267
GBP
Data delayed at least 20 minutes, as of Dec 12 2019 16:35 GMT.
More ▼

Investors Chronicle View

The last IC recommendation on Vectura Group PLC shares was Hold at 82.00 on 10 Sep 2019Read the full article

Board of Directors

1/9

Bruno Angelici, Non-Executive Chairman

2/9

Paul Fry, Chief Financial Officer and Interim Chief Executive Officer

3/9

Susan Foden, Senior Independent Non-Executive Director

4/9

Per-Olof Andersson, Non-Executive Director

5/9

Neil Warner, Non-Executive Director

6/9

Thomas Werner, Non-Executive Director

7/9

Juliet Thompson, Non-Executive Director

8/9

Anne Whitaker, Non-Executive Director

9/9

Kevin Matthews, Non-Executive Director

Contact

Head Office:
Vectura Group plc
One Prospect West 
Chippenham 
Wiltshire
SN14 6FH
 
General enquiries
E: info@vectura.com
T: +44 (0)1249 667700
F: +44 (0)1249 667701

Investor Relations & Analysis:
Elizabeth Knowles
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.